Latest News

Novartis’ arthritis med Ilaris missed the mark in a phase 3 COVID-19 trial. The U.K.’s Recovery Trial added aspirin to the list of repurposed drugs it’s

After several tough years and a CEO switch earlier in 2020, Endo is overhauling its operations—and cutting hundreds of jobs—to better position itself for a drug launch next

China has historically been AstraZeneca’s bright spot, but Pulmicort’s sharp decline there hurt the company’s third-quarter performance. Novartis has made Japan its first CAR-T manufacturing

It is important for patients to have access to high quality and affordable treatment options for chronic conditions. Healthcare professionals and patients can be assured

AiPharma was granted permission to supply a 200mg celecoxib under the brand name of Vobrax. Vobrax can be used for the treatment of rheumatoid arthritis,

PRODUCT BACKGROUND Gastroesophageal reflux disease (GERD) is a condition in which the stomach contents leak backwards from the stomach into the esophagus (the tube from the mouth